Facebook
Twitter
Telegram
Report an ErrorAzurRx BioPharma, Inc. Financial Statements 2011-2024 | AZRX
Annual Financial Statements AzurRx BioPharma, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
40.9 M | 20.4 M | 31.3 M | 37 M | 29.3 M | - | - | - | - | - |
Shares |
28 M | 22.4 M | 15.4 M | 10.6 M | 6.5 M | - | - | - | - | - |
Net Income |
-32.7 T | -15.2 M | -13.5 M | -11.1 M | -14.6 M | -5.93 M | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - |
EBITDA |
-26.4 T | -13.7 M | -12.6 M | -9.33 M | -5.89 M | -4 M | - | - | - | - |
Operating Expenses |
26.4 T | 14.7 M | 13.4 M | 10.1 M | 6.63 M | - | - | - | - | - |
General and Administrative Expenses |
7.29 M | 6.06 M | 8.24 M | - | - | - | - | - | - | - |
All numbers in USD currency